This patent covers the use of TPO (thrombopoietin) for the stimulation of hematopoietic stem cells to differentiate into red blood cells. Classically, as the name implies, TPO is considered a growth factor that induces differentiation of hematopoietic stem cells into the megakaryocytic lineage (ie to make platelets).
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.